Sumitomo Mitsui Financial Group Inc. Sells 1,590 Shares of Humana Inc. $HUM

Sumitomo Mitsui Financial Group Inc. lowered its holdings in Humana Inc. (NYSE:HUM) by 72.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 610 shares of the insurance provider’s stock after selling 1,590 shares during the quarter. Sumitomo Mitsui Financial Group Inc.’s holdings in Humana were worth $148,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in HUM. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Humana by 16.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock valued at $300,728,000 after buying an additional 158,528 shares in the last quarter. Focus Partners Wealth lifted its position in Humana by 104.2% during the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock valued at $1,701,000 after acquiring an additional 3,281 shares during the last quarter. Circle Wealth Management LLC acquired a new stake in Humana in the first quarter valued at approximately $425,000. Swedbank AB grew its holdings in Humana by 5.3% in the second quarter. Swedbank AB now owns 100,397 shares of the insurance provider’s stock worth $24,545,000 after purchasing an additional 5,032 shares during the last quarter. Finally, Kera Capital Partners Inc. acquired a new position in shares of Humana during the second quarter worth $253,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on HUM shares. Wells Fargo & Company upped their target price on Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Sanford C. Bernstein lifted their price objective on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Mizuho lifted their target price on Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Finally, Wall Street Zen downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $295.94.

Humana Trading Up 3.3%

Shares of HUM stock opened at $245.73 on Thursday. The company has a market cap of $29.55 billion, a price-to-earnings ratio of 18.86, a PEG ratio of 1.71 and a beta of 0.42. The stock has a 50 day simple moving average of $263.71 and a 200-day simple moving average of $256.78. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. The firm had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.16 EPS. On average, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is currently 33.18%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.